On July 7, 2021 SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, reported that Eric Francois, Chief Financial Officer, will present at Ladenburg Thalmann’s virtual Healthcare Conference on July 14th, 2021 (Press release, Scynexis, JUL 7, 2021, View Source [SID1234584665]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Conference Information:

The webcast will be made available for 3 months and can be found on the SCYNEXIS website at: View Source